Retailers work with attorney general to provide multilingual Rx information
NEW YORK Attorney General Andrew Cuomo has announced an agreement with CVS and Rite Aid whereby the two pharmacy retailers will counsel all pharmacy customers about prescription information in their own language and will provide written translations in Spanish, Chinese, Italian, Russian, French and Polish.
“Understanding prescription information is a matter of life and death,” Cuomo said. “Our state has always been proud to be home to people from all throughout the world. We need to make sure that all New Yorkers can read and understand the vital information about their medications, regardless of whether English is their first language. CVS and Rite Aid have taken important steps to ensure that customers receive proper assistance in understanding their medication, and my office?s investigation into the practices of other pharmacies continues.”
According to census data, more than one million New Yorkers do no speak English well or at all.
The agreements with the state, which impact more than 2,000 stores statewide, require the pharmacies to:
• Identify whether a customer needs assistance in understanding their prescription medication.
• Inform customers of their right to free assistance in understanding their prescription medication.
• Provide prescription labels and directions regarding dosage and safety information in the six languages that are spoken by more than 1 percent of the population of New York.
• Provide additional assistance in all languages through a service called Language Line.
• Ensure that pharmacy staff counsel customers about their prescription medication in the customer’s own language.
FDA approves Mylan’s generic drug for treating epilepsy
ROCKVILLE, Md. The Food and Drug Administration has approved Mylan’s levetiracetam tablets, FDA records show.
The tablets, a generic version of UCB’s epilepsy drug Keppra, will be available in 250 mg, 500 mg and 750 mg dosages.
The agency’s records indicate an approval date of Nov. 4 and that Mylan’s is the first generic version of Keppra.
Study shows Gardasil is effective in prevention of HPV in males
ATLANTA A vaccine used to prevent genital warts in girls and women works in boys and men, too.
A study of Gardasil funded by its manufacturer, Merck, has shown that the vaccine is effective in preventing infection human papillomavirus in boys and men as well as in girls and women. The study took place in 20 countries among 4,000 boys and men aged 16 to 26, including more than 1,000 in the United States.
Regulatory agencies in 40 countries have approved Gardasil for use in males, but not the Food and Drug Administration, which has approved it only for females aged 9 to 26 because of the lack of evidence of efficacy in males.
Now, however, Merck plans to ask the FDA to extend approval to males. As yet, there is no evidence that the vaccine prevents HPV-related cancers in males.